Concepedia

Adam Konpa

AK

Statistics

Publications

3

Citations

68

H-Index

3

Active since

2022

Affiliations

AstraZeneca (Poland)(Current)

Memorial Sloan Kettering Cancer Center

Duke Cancer Institute

Institut Gustave Roussy

Queen Mary University of London

Adam Konpa is an author at AstraZeneca (Poland) specializing in breast cancer, radiation oncology, and tumor immunity.

Top concepts

Publications per year

2022–2025

3

Publications

3

DESTINY-Breast07: Dose-expansion interim analysis of T-DXd monotherapy and T-DXd + pertuzumab in patients with previously untreated HER2+ mBC.

Fabrice André, Erika Hamilton, Sherene Loi et al. · Journal of Clinical Oncology · 2024 · 27 citations

, , +16

Dose-finding and -expansion studies of trastuzumab deruxtecan in combination with other anti-cancer agents in patients (pts) with advanced/metastatic HER2+ (DESTINY-Breast07 [DB-07]) and HER2-low (DESTINY-Breast08 [DB-08]) breast cancer (BC).

Fabrice André, Erika Hamilton, Sherene Loi et al. · Journal of Clinical Oncology · 2022 · 25 citations

, , +21

Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trial

Nadia Harbeck, Shanu Modi, Lajos Pusztai et al. · Annals of Oncology · 2025 · 16 citations · Full text

1–3 of 3